Van Leeuwenhoeck -- ADO "gravely underrated"

Hi Folks:
My apologies if duplicated, but  I couldn't find any post on the 17 Feb interview linked below.

It's an interview with Van Leeuwenhoeck's Marcel Wijma (founder, md, and chief research officer) on "uncommon biotech opportunities". Anteo is discussed regarding its M&G product, recent DIAsource acquisition, and potential patents for the energy sector. Gotta love Wijma's last line in the interview: "In all, we believe Anteo to be a very promising company that is gravely underrated."

https://www.streetwisereports.com/p...-opportunities-van-leeuwenhoecks-marcel-wijma
(repeated on a few other sites)
https://www.equities.com/news/scanning-the-globe-for-small-cap-biotech-plays
http://www.investorideas.com/news/2016/biotech/02171.asp

P.S. I've been silent on the ADO thread, but have held ADO shares for a year or more.